Incyte Corporation
USE OF PYRAZOLOPYRIMIDINE DERIVATIVES FOR THE TREATMENT OF PI3K-DELTA RELATED DISORDERS
Last updated:
Abstract:
The present application provides methods of treating PI3K.delta. related disorders using compounds of Formula I: ##STR00001## or pharmaceutically acceptable salts thereof.
Status:
Application
Type:
Utility
Filling date:
30 Jun 2021
Issue date:
21 Apr 2022